期刊文献+

HLA超型鉴定技术和疾病关系的研究进展 被引量:2

New advancement in identification of HLA supertype and its relationship with diseases
原文传递
导出
摘要 HLA分子可与带有相同或相似锚着残基的不同抗原肽相结合,提呈一系列含有共同基序的抗原肽产生免疫应答效应。将不同等位基因编码而结合拥有相似共同基序的抗原肽的HLA分子分为不同的家族,称HLA超型;而与HLA结合的表位肽所共有的氨基酸序列特征称超基序。近年来HLA超型的鉴定技术发展迅速,推进了T淋巴细胞免疫应答复杂机制的深入理解,为HLA超型与临床疾病的关系研究提供了支持,同时进一步发展了HLA超型在表位基因疫苗、免疫治疗中的应用。 In immune response, series of antigenic peptides can bind to the human leukocyte antigen (HLA) molecules and form antigen/HLA complexes, the complexes are further recognized by T cells. HLA alleles that share anchor residues similarity and that bind largely overlapping sets of peptides define HLA supertypes; while supermotif is the consensus motif shared by different antigen peptides, which in turn can bind to the corresponding HLA supertype. Recently, the technology of prediction and identification of HLA supertype developed rapidly, which is helpful for understanding the complicated mechanism of T -cell medi- ated immune response. It will also promote the research on the relationship between diseases and HLA supertypes ; Meanwhile, supertypes identification has direct practical implications in epitope -based vaccine development and immunotherapy.
出处 《国际免疫学杂志》 CAS 2008年第2期156-158,F0003,共4页 International Journal of Immunology
基金 青海省2006年科技重点课题资助项目(2006-N-175)
关键词 HLA HLA超型 HLA超基序 HLA HLA supertype HLA Supermotif
  • 相关文献

参考文献18

  • 1Kangueane P, Sakharkar MK, Rajaseger G, et al. A framework to sub-type HLA supertypes. Front Biosci,2005,10:879-886.
  • 2Guan P, Doytchinova IA, Flower DR. A comparative molecular similarity indices (CoMSLA) study of peptide binding to the HLA-A3 superfamily. Bioorg Med Chem,2003,11 (10) :2307-2311.
  • 3Doytchinova IA, Guan P, Flower DR. Quantitative structure-activity relationships and the prediction of MHC supermotifs. Methods, 2004,34 (4) :444-453.
  • 4Doytchinova IA, Flower DR. In silico identification of supertypes for class Ⅱ MHCs. J Immunol,2005,174 ( 11 ) :7085-7095.
  • 5Lund O, Nielsen M, Kesmir C, et al. Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics,2004,55 (12) :797-810.
  • 6Tong JC, Tan TW, Ranganathan S. In silico grouping of peptide/ HLA class Ⅰ complexes using structural interaction characteristics. Bioinformatics ,2007,23 ( 2 ) : 177-183.
  • 7董海龙,隋延仿,叶菁,李增山,曲萍,张秀敏,陈广生,禄韶英.肿瘤抗原MAGE-n HLA-A2限制性细胞毒性T细胞表位的预测及合成鉴定[J].中华医学杂志,2003,83(12):1080-1083. 被引量:10
  • 8Lazaryan A,Lobashevsky E,Mulenga J,et al . Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native Africans. J Virol,2006,80(12) :6056-6060.
  • 9Den Uyl D, Vander Horst-Bruinsma IE, Van Agtmael M . Progression of HIV to AIDS: a protective role for HLA-B27? AIDS Rev, 2004,6 (2) : 89-96.
  • 10Gibert M, Balandraud N, Touinssi M, et al . Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis: The protective effect. Hum Immunol,2003,64(10) :930-935.

二级参考文献14

  • 1Boon T, Van Pel A. T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by trascription and translation of short subgenic regions. A hypothesis. Immuno Genetics,1989, 29:75-79.
  • 2Thurner B, Haendle I, Roder C, et al. Vaccination with MAGE-3A1 peptide-plused mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage Ⅳ melanoma. J Exp Med, 1999, 190:1669-1678.
  • 3Dagher R, Long LM, Read EJ, et al. Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study. Med Pediatr Oncol, 2002, 38:158-164.
  • 4Rammensee HG, Bachmann J, Emmerich NPN, et al. SYFPEITHI:database for MHC ligands and peptide motifs. Immunogenetics,1999,50:213-219.
  • 5Gulukota K, Sidney J, Sette A, et al. Two complementary methods for predicting peptides binding major histocompatibility complex molecules. J Mol Biol, 1997, 267:1258-1267.
  • 6Pascolo S, Schirle M, Guckel B, et al. A MAGE-A1 HLA- A*0201 epitope identified by mass spectrometry. Cancer Res, 2001,61: 4072-4077.
  • 7Kawashima I, Hudson SJ, Tsai V, et al. The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors. Hum Immunol, 1998, 59:1-14.
  • 8van der Bruggen P, Bastin J, Gajewski T, et al. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J Immunol, 1994, 24:3038-3043.
  • 9Falk K, Rotzschke O, Stevanovic S, et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature, 1991,351: 290-296.
  • 10Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol, 1994, 152:163-175.

共引文献9

同被引文献31

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部